赢创，华恒生物，生物制造重磅合作！

Core Viewpoint - The strategic partnership between Huaheng Biotechnology and Evonik aims to leverage their respective strengths to provide high-quality bio-based amino acid products, promoting innovation and development in the animal nutrition sector [2][4][5]. Group 1: Strategic Partnership - Huaheng Biotechnology and Evonik signed a memorandum of understanding to collaborate on bio-based amino acids for animal nutrition [2]. - Evonik has over 60 years of experience in essential amino acids for animal nutrition, providing a mature solution and extensive global marketing network [4]. - The partnership will integrate resources to enhance the supply chain and offer superior products and services, contributing to sustainable development in the global animal nutrition and feed industry [4]. Group 2: Project Developments - Huaheng Biotechnology plans to adjust its production projects, maintaining a total capacity of 50,000 tons per year for bio-based succinic acid and introducing flexible production for L-valine and myo-inositol [6]. - The company is investing 39 million yuan in an AI-driven bio-manufacturing research and pilot demonstration base, expected to achieve a comprehensive pilot scale of 5,500 tons [7]. - A project for resource utilization of amino acid mother liquor is set with an investment of 40 million yuan, aiming for an annual production capacity of 26,000 tons of peptide granules [8]. Group 3: Future Initiatives - Huaheng Biotechnology announced plans to invest 320 million yuan in an AI precision fermentation and protein engineering shared demonstration project, focusing on real-time monitoring and optimization of production processes [9]. - The company is preparing for an overseas share issuance and plans to list on the Hong Kong Stock Exchange [9]. Group 4: Upcoming Events - The 2025 Synthetic Biology and Green Bio-Manufacturing Conference will be held in Ningbo, focusing on AI and bio-manufacturing, with various forums and discussions scheduled [11][12].